Not applicableUnknownNCT03869502What this trial is testingEuropean CML Blast Crisis RegisterWho this might be right forChronic Myeloid Leukemia in Myeloid Blast Crisis University of Jena 250
Early research (Phase 1)Ended earlyNCT04526795What this trial is testingFludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory LeukemiaWho this might be right forBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Lymphoblastic Leukemia+8 more M.D. Anderson Cancer Center 19
Early research (Phase 1)Study completedNCT00293410What this trial is testingClofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 70
Not applicableEnded earlyNCT00899951What this trial is testingStudying Fentanyl in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00818961What this trial is testingDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Northside Hospital, Inc. 36
Early research (Phase 1)Study completedNCT00104975What this trial is testingAlemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Yale University 20
Testing effectiveness (Phase 2)Ended earlyNCT00066417What this trial is testingPeripheral Stem Cell Transplant in Treating Patients With High-Risk LeukemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases National Heart, Lung, and Blood Institute (NHLBI) 51
Early research (Phase 1)Study completedNCT00003243What this trial is testingCombination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Early research (Phase 1)Study completedNCT00098436What this trial is testingTemozolomide and VNP40101M in Treating Patients With Relapsed or Refractory LeukemiasWho this might be right forLeukemia Vion Pharmaceuticals 25
Testing effectiveness (Phase 2)WithdrawnNCT00594555What this trial is testingA Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia, Blast CrisisAcute Myeloid Leukemia University of Cincinnati 20
Early research (Phase 1)Study completedNCT01204164What this trial is testingPhase 1 Study of TG02 Citrate in Patients With Advanced Hematological MalignanciesWho this might be right forAMLALLBlast Crisis+2 more Tragara Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00077467What this trial is testingBortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00134017What this trial is testingCombination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Not applicableApproved For MarketingNCT00905593What this trial is testingNilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00081874What this trial is testingRAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaWho this might be right forLeukemiaMantle Cell LymphomaMyelofibrosis M.D. Anderson Cancer Center 29